by Jessica Etheridge | Jun 27, 2019 | Articles, ColoPlex, Company Details, Featured, News and Events
By Milt Capps Published June 18, 2019 Comment Print Chairman Tom Boyd, CEO Eric Mayer KNOXVILLE’s EDP Biotech, which was chartered to commercialize assays for early detection of disease and is now focused on its blood-based ColoPlex™ test for colorectal...
by Jessica Etheridge | Jun 3, 2019 | Articles, ColoPlex, Colorectal Cancer, Featured, News and Events
NEW YORK (GenomeWeb) – In vitro diagnostics developer EDP Biotech said today it has signed a deal with Luminex to develop, market, and sell a blood-based colorectal test using the xMAP technology. Terms of the deal were not disclosed. Called ColoPlex, the inexpensive...
by Jessica Etheridge | Mar 25, 2019 | ColoPlex, Colorectal Cancer, Featured, News and Events
A large crowd filled the reception area and several of the other work and lab spaces as EDP BioTech Corporation held an event to shine the spotlight on “Colorectal Cancer Awareness Month” as well as its progress in developing its early detection technology. The local...
by Jessica Etheridge | Mar 5, 2019 | Articles, Colorectal Cancer, Featured, News and Events
Kineticos Life Science Consulting: Oncology Diagnostics Panel Session As the oncology landscape continues to grow and develop, the diagnostics developed and used will need to keep pace with the therapeutics. To help us understand exactly what it will take to do so,...
by Jessica Etheridge | Dec 19, 2018 | Articles, ColoPlex, Company Details, Featured, News and Events
SAN FRANCISCO, December 2018 – US Capital Global Securities, an affiliate of US Capital Global, is offering to accredited investors a $5 million preferred equity investment in the privately held medical device company, EDP Biotech Corporation (“EDP Biotech”). Click...
